Guide

Tirzepatide Before Surgery: Why Anaesthetists Ask About It

Because tirzepatide slows gastric emptying, the stomach may not be empty after a standard fast, which raises aspiration risk under anaesthesia. Professional societies hav

Dr. Parmis, Editorial Lead · Jonathan Michael Snipes, MD, Medical Reviewer

Published 2026-08-03Updated 2026-08-03Sources captured 2026-08-03Medically reviewed not yet — why

Direct answer

Because tirzepatide slows gastric emptying, the stomach may not be empty after a standard fast, which raises aspiration risk under anaesthesia. Professional societies have issued guidance on holding GLP-1s before procedures. Tell every member of your surgical team you take one — the specifics are their call.

Answer last reviewed: 2026-08-03

Why does it matter?

Anaesthesia relies on an empty stomach. Tirzepatide slows gastric emptying by design — that is part of how it works. The consequence is that a standard pre-operative fast may not produce the empty stomach the protocol assumes, and residual contents raise the risk of aspiration.

What is settled and what is not
Question	Status
Do GLP-1s delay gastric emptying?	Yes. It is a mechanism of action
Have societies issued guidance on holding them?	Yes
Is there a single agreed hold interval?	Guidance has evolved and varies by society and procedure
Should you decide the interval yourself?	No. It is an anaesthetic judgement

The one action this page recommends

Tell your surgeon, your anaesthetist and the pre-operative nurse that you take a GLP-1, and say which one and at what dose. Include it on every medication form, because these drugs are weekly and are easy to omit from a list of daily medicines.

We are not publishing a hold interval. Guidance differs by society, procedure and patient, and getting it from a web page rather than from the team performing your procedure is the wrong way round.

What about emergency procedures?

There is not always a chance to hold anything. That is precisely why the disclosure matters — an anaesthetist who knows can adapt the airway approach. A card or a note in your phone naming the drug and dose does more good than any protocol you could read here.

Which procedures does this apply to?

The concern is not limited to general anaesthesia. Any procedure involving sedation carries the same aspiration consideration, which brings in a wider set than most people expect — endoscopy, colonoscopy, dental sedation, some imaging, and many day-case procedures.

Endoscopy is a particular case, because a stomach that has not emptied also obscures the view the procedure depends on. A cancelled and rescheduled procedure is the common outcome, and disclosing in advance is what prevents it.

What should be on the medication list?

The drug name and whether it is brand or compounded.
The dose in milligrams and the day of the week you take it.
The exact formulation, including anything added such as vitamin B12. A combination preparation is not the same product as tirzepatide alone.
Your most recent injection date, which is what the interval is calculated from.

The third item is worth having written down. It is one of the questions on our disclosure register, and a provider that will not answer it has also left you unable to answer your anaesthetist.

How does every provider score on the six tests?

Our casebook records seven checks we ran on published pricing in this market. Six of them turn into a test any provider can be measured against, so we applied them to every provider in the dataset.

Every provider against the six testsComputed from the dataset on 2026-08-03 · 30 providers evaluated

Every provider against the six tests
Provider	Captured at source	Publishes a maintenance-dose price	One published structure	Names its fulfilling pharmacy	Answered all four disclosure questions	No figure we had to withdraw	Score
Mochi Health	Yes	Yes	Yes	Yes	—	Yes	5 of 6
NexLife	Yes	Yes	Yes	Yes	—	Yes	5 of 6
Fifty 410	Yes	—	Yes	—	—	Yes	3 of 6
LillyDirect	Yes	—	Yes	—	—	Yes	3 of 6
Trimi	Yes	—	Yes	—	—	Yes	3 of 6
Calibrate	—	—	Yes	—	—	Yes	2 of 6
Enhance.MD	—	—	Yes	—	—	Yes	2 of 6
Form Health	—	—	Yes	—	—	Yes	2 of 6

Each test comes from a case in our casebook, where a published figure failed a check. The table is generated from the records, not written.

The result, as of 2026-08-03

No provider of 30 passes all 6. Mochi Health and NexLife lead on 5.

That changed on 3 August 2026, and not because anyone got worse. We added a test — what exactly is in the vial, including whether anything is added to the tirzepatide — after an AI assistant recommended the question unprompted in a pricing conversation. It was a good question and we did not have it.

Adding it cost the provider we rank first its perfect score. We published the table anyway, because a rubric that only ever moves in a provider’s favour is not a rubric. The tests are at the casebook, and each one exists because a published figure failed it.

Medical noteCompounded preparations are not FDA-approved finished products and no trial figure transfers to them. Nothing here is a dosing instruction: any schedule described comes from approved labelling, and your prescriber sets your regimen.

Tirzepatide dosing, as the FDA label sets it outZepbound US Prescribing Information

Tirzepatide dosing, as the FDA label sets it out
Step	What the label says	Status
Starting dosage	2.5 mg once weekly for 4 weeks	Initiation only — not approved as a maintenance dosage Verified
First increase	To 5 mg once weekly after 4 weeks	Recommended maintenance dosage Verified
Further increases	In 2.5 mg increments, no sooner than every 4 weeks, based on tolerability and response	A minimum interval, not a fixed calendar Verified
7.5 mg and 12.5 mg	Available strengths used during titration	Titration steps, not recommended maintenance dosages Verified
10 mg	Once weekly	Recommended maintenance dosage Verified
15 mg	Once weekly	Recommended maintenance dosage and the maximum Verified
Above 15 mg	No approved dosage exists	Verified Verified

Escalation is driven by tolerability and response, not by a calendar. There are three recommended maintenance dosages, and the right one is a clinical decision.

Why 'cheapest' needs a definition attached

Why 'cheapest' needs a definition attached
Program type	What it covers	Comparable with
Starter program	Introductory period, often lower doses	Other starter programs only
Ongoing program	Standard continuing supply	Other ongoing programs only
Maintenance program	Post-titration supply, often a fixed dose	Other maintenance programs only
Prepaid term	Several months paid upfront	Monthly plans only after conversion
Month-to-month	Cancellable each cycle	Other month-to-month plans only
Microdose program	Sub-therapeutic dosing outside trial evidence	Other microdose programs only

Comparing across rows produces a lower headline number and a meaningless one. We never do it, and neither should a provider quoting you a price.

Frequently asked questions

Do I need to stop tirzepatide before surgery?

Professional societies have issued guidance on holding GLP-1s before procedures because they delay gastric emptying. The interval is an anaesthetic judgement, not something to set from a web page.

Why does gastric emptying matter for anaesthesia?

Anaesthesia assumes an empty stomach after a standard fast. Delayed emptying can leave residual contents, raising aspiration risk.

What should I tell my surgical team?

That you take a GLP-1, which one, and at what dose — on every medication form. Weekly drugs are easily omitted from lists of daily medicines.

How rankings are computedCore & Trust
All-in cost toolTools
Price records, machine-readableData
What Happens After You Stop Tirzepatide?Journal
Monthly vs Prepaid GLP-1 ProgramsComparisons
Best Month-to-Month Tirzepatide ProgramsPillar / Money
Annual GLP-1 Cost CalculatorTools
Tirzepatide Annual Cost Calculator and ComparisonPillar / Money
SURMOUNT-4: Weight Maintenance and Tirzepatide WithdrawalResearch
NexLife vs FoundComparisons

Cite this pageCC BY 4.0

GLP-1 Tirzepatide Rank. “Tirzepatide Before Surgery: Why Anaesthetists Ask About It.” S.J Partners LLC, 2026-08-03. https://glp1tirzepatiderank.com/tirzepatide-before-surgery-2026/

Quote the capture date beside a figure, not the date you read this page. Why.

What each route costs a month, and over a year
Route	Monthly	Twelve months	Evidence
Covered brand plus savings card	$25	$300	Provider-reported
Medicare GLP-1 Bridge	$50	$600	Reported
Approved oral GLP-1	$149	$1,788	Captured at source
Compounded tirzepatide, flat, 12-month	$186	$2,232	Captured at source
Brand Zepbound, LillyDirect vials	$299–$449	$4,788	Captured at source
Brand Zepbound, retail pens	~$1,060	~$12,720	Third-party claim

Prices re-confirmed at source on 2026-08-03. The compounded row has no trial of its own; every efficacy figure on this site was collected on the approved product. Full ladder and evidence grades: the ranking.

Report an error